Clinical Trials Browser

Phase 2 × Chlorambucil × 90 days × Clear all

NCT01808599 2026-01-15

Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma

Phase 2 Active not recruiting

Lymphoma, B-Cell, Marginal Zone